| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214403A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214345A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214330A1 Benzimidazole derivatives and combinatorial libraries thereof |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214323A1 Indoloazepines as vasopressin receptor antagonists |
| 06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
| 06/19/2002 | EP1214320A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 06/19/2002 | EP1214319A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214317A1 Antiviral agents |
| 06/19/2002 | EP1214314A2 Aminopiperidine derivatives as antibacterials |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214302A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 06/19/2002 | EP1214300A2 Rate-controlled particles |
| 06/19/2002 | EP1214299A1 Muscarinic antagonists |
| 06/19/2002 | EP1214298A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214287A1 Amides as inhibitors for pyruvate dehydrogenase |
| 06/19/2002 | EP1214129A1 Process for producing fine medicinal substances |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214096A2 Taxane prodrugs |
| 06/19/2002 | EP1214094A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214093A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 06/19/2002 | EP1214092A2 Method of potentiating chemotherapy and treating solid tumors |
| 06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 06/19/2002 | EP1214087A1 Combination treatment with il-1ra and compounds that inhibit il-1 processing and release |
| 06/19/2002 | EP1214086A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 06/19/2002 | EP1214084A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/19/2002 | EP1214080A1 Glucosamine and egg for reducing inflammation |
| 06/19/2002 | EP1214079A1 Drug for treating fractures |
| 06/19/2002 | EP1214078A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 06/19/2002 | EP1214077A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 06/19/2002 | EP1214076A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 06/19/2002 | EP1214075A1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 06/19/2002 | EP1214074A2 Dioxolane nucleoside analogs for the treatment or prevention of viral infection |
| 06/19/2002 | EP1214073A2 Use of dexrazoxane for treating psoriasis |
| 06/19/2002 | EP1214072A2 Use of desloratadine for treating allergic and inflammatory conditions |
| 06/19/2002 | EP1214071A2 Treating allergic and inflammatory conditions using desloratadine |
| 06/19/2002 | EP1214070A2 Polyhydroxylated benzene-containing compounds |
| 06/19/2002 | EP1214068A1 Ophthalmic fluid |
| 06/19/2002 | EP1214067A1 Methods for treating cell proliferative disorders including cancer |
| 06/19/2002 | EP1214066A1 Formation of nanometer-scale structures |
| 06/19/2002 | EP1214065A1 A method for optimizing pupil size using alpha antagonist |
| 06/19/2002 | EP1214064A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 06/19/2002 | EP1214063A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 06/19/2002 | EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 06/19/2002 | EP1214061A2 Use of docetaxel for treating hepatocellular carcinoma |
| 06/19/2002 | EP1214060A2 Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48 |
| 06/19/2002 | EP1214059A2 Surface modified particulate compositions of biologically active substances |
| 06/19/2002 | EP1214057A1 Vascular coating composition |
| 06/19/2002 | EP1214056A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/19/2002 | EP1214055A2 Pharmaceutical gel containing active substances |
| 06/19/2002 | EP1214052A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 06/19/2002 | EP1214048A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 06/19/2002 | EP1214041A2 Combination therapy for the treatment of sepsis |
| 06/19/2002 | EP1214040A1 Extracts of orange peel for prevention and treatment of cancer |
| 06/19/2002 | EP1214039A2 Methods and compositions for preventing and treating urinary tract disorders |
| 06/19/2002 | EP1214038A2 Methods and compositions for preventing and treating prostate disorders |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | EP1213971A1 Improving condition of elderly pets |
| 06/19/2002 | EP1213965A1 Thrombopoietin mimetics |
| 06/19/2002 | EP1213964A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 06/19/2002 | EP1165596B1 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/19/2002 | EP1105395B1 Photocyclized rapamycins |
| 06/19/2002 | EP1067903B1 Improved crystal structure |
| 06/19/2002 | EP1056769B1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 06/19/2002 | EP1042326B1 Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 06/19/2002 | EP1014943B1 Medical aerosol formulations |
| 06/19/2002 | EP1001769B1 Soluble prodrugs of paclitaxel |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0973725B1 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives |
| 06/19/2002 | EP0946149B1 Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations |
| 06/19/2002 | EP0941054B1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 06/19/2002 | EP0937092B1 Solid support matrices containing a toxin binding oligosaccharide |
| 06/19/2002 | EP0906101B1 Slow-release pharmaceutical formulations containing mizolastin |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0885233B1 Terpyridine-platinum(ii) complexes |
| 06/19/2002 | EP0877750B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
| 06/19/2002 | EP0877619B1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions |
| 06/19/2002 | EP0869817B1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0861084B1 Improved process and composition for therapeutic cisplatin (cddp) |
| 06/19/2002 | EP0852497B1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |